Primo Medical Group announced that it completed the $100 million sale of spin-off company Arthrosurface to Anika Therapeutics (NSDQ:ANIK). Under the agreement, Anika is set to acquire all outstanding shares of Arthrosurface in exchange for $100 million in total, starting with an upfront payment of approximately $60 million in cash from Anika’s existing balance sheet. The […]
FDA clears Arthrosurface’s Boss toe implant
Arthrosurface said yesterday that it received FDA 510(k) clearance for its Boss toe fixation system, which the company believes will be commercially available at the end of the month. The Franklin, Mass.-based company said the Boss system is designed to improve stabilization in the first metatarsal with a distal bone void and to provide patients […]
Rethinking orthopedic implants with Arthrosurface CEO Steve Ek | DeviceTalks Podcast
Arthrosurface president & CEO Steve Ek talked to reporter Sarah Faulkner about the company’s motion-preserving joint replacement technology. Want to see these interviews live? Join us at DeviceTalks. Sarah: Steve’s office is not your typical corporate office. It’s filled with models of the human skeletal system and demos of the company’s implants. It’s a good […]
Arthrosurface touts Ovo shoulder study
Arthrosurface said last week that data from a study of its Ovo with inlay glenoid shoulder arthroplasty system showed strengths in pain relief, patient satisfaction and functional improvements in patients with glenohumeral arthritis. The Franklin, Mass.-based company’s OvoMotion is a stemless total shoulder system is designed to minimize bone removal specifically for patients with painful […]
Arthrosurface nabs 510(k) clearance for patellofemoral WaveKahuna arthroplasty system
Arthrosurface said last month that it won 510(k) clearance from the FDA for its patellofemoral WaveKahuna arthroplasty system. The Franklin, Mass.-based company’s PF WaveKahuna device is designed to restore the articular surface geometry of the patella and femoral trochlea. The system tackles the challenging PF tracking and stability conditions and gives increased coverage of the […]
Arthrosurface wins FDA nod for OVOMotion shoulder arthroplasty system
Arthrosurface said yesterday it won FDA 510(k) clearance for its OVOMotion shoulder arthroplasty system. The Franklin, Mass.-based company said the newly cleared stemless total shoulder system is designed to minimize bone removal specifically for patients with painful or severely disabled shoulder joints from arthritis, traumatic events or avascular necrosis. “This truly is a revolutionary stemless […]
Arthrosurface acquires allograft tech from Wasas
Arthrosurface said today that it paid an unspecified amount to acquire an acellular dermal stabilization device technology from Wasas LLC. Derived from human tissue, acellular dermis is made using a process that removes cells but retains portions of the extracellular matrix to create dermal allografts. The deal includes the patent rights for the technology, which Franklin, Mass.-based Arthrosurface […]
Arthrosurface touts FDA win for ToeMotion Total Toe tech
Massachusetts-based joint devices maker Arthrosurface landed FDA clearance for its ToeMotion Total Toe fixation system, the company announced this month.
Launched during the AAOS conference in New Orleans, the ToeMotion Total Toe system aims to fix the joint and preserve bone without jeopardizing the stability of the toe.
Arthrosurface passes the 20,000-patient mark
Arthrosurface’s joint preservation devices have made their way into the joints of over 20,000 patients.
The Franklin, Mass.-based company’s inlay joint resurfacing systems have treated over 20,000 patients, with 98% of the screw-in devices still in place.
The company said its products delay the need for joint replacements while preserving the active lifestyles of its Baby-Boomer customers.